Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: Sitagliptin Umbilical Cord Blood Transplant Study [Phase 2]
Phase 2 clinical trial update on sitagliptin in the setting of umbilical cord blood transplantation, with results posted in 2016 for several…
-
CLINICAL_TRIALS trial_result · 2016-07-25Clinical Trial Update: Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus [Phase 2]
Phase 2 study evaluating unrelated cord blood transplantation using tacrolimus and sirolimus for hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating combination chemotherapy and monoclonal antibody therapy in Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders [Phase 2]
A Phase 2 trial testing nonmyeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors for multiple hematologic dis…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating a combination chemotherapy regimen for relapsed or refractory intermediate- or high-grade Non-Hodgkin ly…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial comparing two combination chemotherapy regimens in previously untreated patients with aggressive Non-Hodgkin lymphoma (stages …
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease [Phase 2]
Phase 2 trial update on Rituximab for Non-Hodgkin's lymphoma or Hodgkin's disease; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: A Phase Ib Study of the Safety, Tolerability and Efficacy of LY2780301 in Combination With Gemcitabine [Phase 1]
Phase Ib trial assessing safety, tolerability, and preliminary efficacy of LY2780301 in combination with gemcitabine in solid tumors and non…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies [Phase 1]
Phase 1 study of idelalisib (IPI-145) in combination with Rituximab or Bendamustine/Rituximab in hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial evaluating the combination of Yttrium-90 ibritumomab tiuxetan and rituximab in patients with Non-Hodgkin lymphoma has comple…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Rituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab in combination with galiximab for non-Hodgkin lymphoma has completed, with results not detailed in the pr…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
A diagnostic study in patients with aggressive non-Hodgkin's lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia [Phase 2]
A Phase 2 trial of a combination chemotherapy regimen for non-Hodgkin lymphoma and acute lymphoblastic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 study evaluating the efficacy and safety of etoposide in patients with relapsed non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: Pilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell Malignancies [Phase 1, Phase 2]
Phase 1/Phase 2 pilot study evaluating autologous T lymphocytes with antibody-dependent cellular cytotoxicity in CD20-positive B-cell malign…
-
CLINICAL_TRIALS trial_result · 2016-06-10Clinical Trial Update: Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors [EARLY_Phase 1]
Early-phase 1 clinical trial update for nelfinavir in gammaherpesvirus-related tumors, noting termination of the study despite investigation…
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial update of aflibercept (VEGF Trap) in patients with relapsed or refractory solid tumors or Non-Hodgkin's lymphoma; the study ha…
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: VEGF Trap in Treating Patients With Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial evaluating VEGF Trap (aflibercept) in patients with solid tumors or Non-Hodgkin's lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
A Phase 1 trial update of intravenous aflibercept (VEGF trap) in patients with relapsed or refractory advanced solid tumors or non-Hodgkin l…
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
A Regeneron-sponsored Phase 1 trial evaluating intravenous aflibercept (VEGF trap) in patients with relapsed or refractory advanced solid tu…
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Imaging Based Dosimetry for Individualized Internal Emitter Therapy
Completed trial evaluating imaging-based dosimetry to individualize internal emitter therapy for Non-Hodgkin's Lymphoma.
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma [Phase 1]
Phase 1 trial evaluating aflibercept in combination with standard R-CHOP chemotherapy in first-line non-Hodgkin B-cell lymphoma; the study s…
-
CLINICAL_TRIALS trial_result · 2016-05-05Clinical Trial Update: Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant
A Duke University registry study evaluating T-cell depleted allogeneic non-myeloablative stem cell transplantation for hematologic cancers h…
-
CLINICAL_TRIALS trial_result · 2016-05-02Clinical Trial Update: Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation [Phase 2]
Phase 2 clinical trial evaluating repeat transplantation for relapsed or refractory hematologic malignancies after prior transplant; the stu…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Treosulfan-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies [Phase 2]
Phase 2 trial evaluating treosulfan-based conditioning for allogeneic stem cell transplantation in lymphoid malignancies is being updated. T…